Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy

Jonathan Belsey, Simon de Lusignan, Jeremy van Vlymen, Tom Chan, Nigel Hague
  • Current Medical Research and Opinion, August 2008, Informa Healthcare
  • DOI: 10.1185/03007990802374633

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Simon de Lusignan

In partnership with: